e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The polyamine spermine is increased in cystic fibrosis airway secretions
H. Grasemann, D. Shehnaz, P. Pencharz, F. Ratjen (Toronto, Canada)
Source:
Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session:
Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session type:
Oral Presentation
Number:
365
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Grasemann, D. Shehnaz, P. Pencharz, F. Ratjen (Toronto, Canada). The polyamine spermine is increased in cystic fibrosis airway secretions. Eur Respir J 2011; 38: Suppl. 55, 365
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Regulation of ion transporters and airway surface dynamics by lipoxin in cystic fibrosis bronchial epithelium
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011
The relationship between airway bacterial load and airways inflammation in stable non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Year: 2011
Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function
Source: Eur Respir J 2014; 44: 1253-1261
Year: 2014
Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
Characterization of cystic fibrosis airway epithelium
in vitro
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004
Bronchial hyperreactivity in cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 616s
Year: 2004
Bronchial hyperreactivity in cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002
Airway surface pH in subjects with cystic fibrosis
Source: Eur Respir J 2003; 21: 37-42
Year: 2003
Bronchial immunoglobulins and epithelial pIgR are upregulated in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
via
hydration
Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021
Year: 2022
Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002
Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006
Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect
Source: Eur Respir J 2004; 24: 95-100
Year: 2004
Treatment of atelectasis and severe mucus plugging in cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Measurement of airways obstruction among preschoolers with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept